INS and diabetes mellitus: Insulin aggregation, on the other hand, is primarily an iatrogenic (treatment-induced) or pharmaceutical problem that impacts the effectiveness and safety of insulin therapy, but it is not a part of the underlying biological mechanisms that cause diabetes in the first place.